ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,035.69
-1.57%
Dow Jones
37,815.92
-1.49%
US Dollar vs MXN
17.1359
-0.10%
Brent Oil
85.56
-0.39%
Bitcoin
60,208.04
-0.65%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. BioCardia Inc (BCDA)

  7. BioCardia Inc (BCDA) Noticias

BCDA BioCardia Inc

0.3803
0.0103 (2.78%)
30 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
BioCardia Inc BCDA NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.0103 2.78% 0.3803 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.37 0.37 0.40 0.3871 0.37
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
25/4/202408:00GLOBEBioCardia Completes Enrollment of CardiAMP Cell Therapy for..
27/3/202415:00GLOBEBioCardia Reports Fourth Quarter and Full Year 2023 Business..
20/3/202406:00GLOBEBioCardia to Host 2023 Financial Results and Corporate..
13/3/202406:00GLOBEBioCardia and StemCardia Announce Biotherapeutic Delivery..
12/3/202406:00GLOBEBioCardia Announces CMS Approval of Coverage for CardiAMP..
04/3/202407:00EDGAR2Form 8-K - Current report
04/3/202407:00GLOBEBioCardia Reports Positive Interim Results from Phase III..
27/2/202415:53EDGAR2Form SC 13D/A - General statement of acquisition of..
15/2/202406:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202416:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202415:17EDGAR2Form S-3 - Registration statement under Securities Act of..
09/2/202408:58EDGAR2Form 8-K - Current report
08/2/202406:03EDGAR2Form 8-K - Current report
08/2/202406:00GLOBEBioCardia Announces Activation of CardiAMP Heart Failure II..
06/2/202415:28EDGAR2Form SC 13D/A - General statement of acquisition of..
02/2/202413:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202406:00EDGAR2Form 8-K - Current report
31/1/202406:00GLOBEBioCardia Announces Two Scientific Abstracts Have Been..
03/1/202406:00EDGAR2Form 8-K - Current report
03/1/202406:00GLOBEBioCardia Biotherapeutic Delivery and Morph Access..
19/12/202306:00EDGAR2Form 8-K - Current report
19/12/202306:00GLOBEBioCardia Doses First Patient in CardiALLO Phase I/II..
18/12/202306:16GLOBEBioCardia Announces Expected CardiAMP Heart Failure Japan..
18/12/202306:00EDGAR2Form 8-K - Current report
06/12/202305:05EDGAR2Form 8-K - Current report
06/12/202305:03EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
05/12/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
05/12/202315:11EDGAR2Form 8-K/A - Current report: [Amend]
05/12/202315:05EDGAR2Form 8-K - Current report
29/11/202306:00EDGAR2Form 8-K - Current report
29/11/202306:00GLOBEBioCardia Shares Update from Japan PMDA Consultation on..
17/11/202316:25EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
16/11/202316:15EDGAR2Form 8-K - Current report
16/11/202311:56GLOBEBioCardia Announces $1.3 Million Registered Direct Offering..
14/11/202306:15GLOBEBioCardia Announces FDA Approval of CardiAMP Heart Failure..
08/11/202315:11GLOBEBioCardia Reports Third Quarter 2023 Business Highlights and..
08/11/202315:08EDGAR2Form 8-K - Current report
08/11/202315:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202316:04GLOBEBioCardia to Host Q3 2023 Corporate Update and Financial..
20/10/202308:26EDGAR2Form S-3 - Registration statement under Securities Act of..
19/10/202316:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/10/202316:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/10/202316:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/10/202316:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/10/202316:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/10/202316:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/10/202316:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
18/10/202315:30EDGAR2Form 8-K - Current report
11/10/202305:04EDGAR2Form 8-K - Current report
11/10/202305:00GLOBEBioCardia Announces Completion of Enrollment in Phase III..

Su Consulta Reciente

NASDAQ
BCDA
BioCardia
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados